What's on the web on your pursuit, hobbies, interests and worries

TardiveDyskinesia news

Discussing The Market Potential Of Neurocrine's Ingrezza For Tardive Dyskinesia After April 11th PDUFA

Seeking Alpha - Apr 19, 2017
We're interviewing an expert on Neurocrine's recently approved drug Ingrezza for Tardive Dyskinesia (TD). The call will occur on Wednesday, April 19th at 1:30pm ET. Shares have increased about 30% since approval, and investors are wondering if this is ...

Neurocrine's Stock Up, FDA Nod for Tardive Dyskinesia Drug

Yahoo Finance - Apr 13, 2017
Shares of Neurocrine Biosciences, Inc. NBIX soared 25% on Tuesday after announcing the FDA approval ofIngrezza (valbenazine) capsules a day before for the treatment of adults with tardive dyskinesia (TD). Ingrezza is the first and the only drug ...

Dr Aimee Tharaldson Discusses 2 New Treatments for Tardive Dyskinesia

AJMC.com Managed Markets Network - Apr 12, 2017
The market for tardive dyskinesia, a movement disorder affecting 500,000 patients in the United States, will go from zero approved treatments to 2 in 2017, making it an important area to watch, said Aimee Tharaldson, PharmD, senior clinical consultant ...

Tardive Dyskinesia - premium items on eBay

NEW Tardive Dyskinesia: Research & Treatment


Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association


NEW Tardive Dyskinesia by Fann William Paperback Book (English) Free Shipping


>> Go to all great Tardive Dyskinesia deals on eBay

Tardive Dyskinesia books

Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association

by: American Psychiatric Association

This book summarizes the progress made over the last decade in understanding the differential diagnosis and epidemiology of tardive dyskinesia, as well as risk factors, course, and treatment.

>> More info on Amazon

Tardive Dyskinesia: Research & Treatment

In the late 1960's I summarized the literature on tardive dyskinesia and found about forty-five papers on this disorder; when I reviewed this topic 4 years later there were fifty additional communications. It was hardly an impressive number ofreports and certainly small by comparison to the prolific output of psychopharmacologists in other areas. Yet there was sufficient information to be concerned about this new and unexpected complication. The majority of psychiatrists either ignored the existence of the problem or made futile efforts to prove that these motor abnormalities were clinically insignific­ ant or unrelated to drug therapy.
>> More info on Amazon

Understanding and Treating Tardive Dyskinesia

by: Dilip V. Jeste MD, Richard Jed Wyatt
Book by Jeste MD, Dilip V., Wyatt, Richard Jed
>> More info on Amazon

Drug-Induced Movement Disorders

Drug-Induced Movement Disorders rigorously analyzes established and emerging facts surrounding drug-induced dystonia, dyskinesia, akathisia, parkinsonism, and other acute and tardive movement disorders liable to result from medicinal use of dopamine blocking agents, antidepressants, levodopa, anticonvulsants, and other drugs-providing professionals effective tools for predicting, identifying, and proactively managing these often treatable, and frequently preventable, conditions.
>> More info on Amazon

>> Go to all Tardive Dyskinesia books

Tardive Dyskinesia pictures on the web

>> Show

Tardive Dyskinesia videos

Tardive Dyskinesia

The Abnormal Involuntary Movement Scale (AIMSDVD.com)Training DVD is a unique resource for educators. It visually presents the AIMS exam & the entire ...

Extra Pyramidal Side Effects (EPSE) Examination - Tardive Dyskinesia

Extra Pyramidal Side Effects (EPSE) Examination - Tardive Dyskinesia: EPSE examination based on the gold standard Abnormal Involuntary Movement Scale.

Tardive Dyskinesia Symptoms


FDA approves first drug to treat Tardive dyskinesia

The U.S. Food and Drug Administration approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the ...

Awareness of Tardive Dyskinesia

This is from taken Seroquel.